Clinical research evaluates the benefits of lymph node dissection in hemicolectomy, indicating precision strategies are vital.
A minimum of 12 lymph nodes examined is a requirement for the pathological specimens of radical colon cancer surgery according to the NCCN guidelines. However, the increase in the number of lymph nodes examined by expanding the range of lymph node dissection is not the fundamental factor. Addressing whether the range of lymph node dissection brings benefits requires evidence from researches. In recent years, high-level evidence brought by the RELARC trial has defined the indications for central lymph node dissection in the right hemicolectomy. Clinical research on indications for infrapyloric and gastroepiploic lymph nodes and non-regional/non-feeding vessel lymph node dissection has also been carried out. This article provides strategic references in the era of precision medicine by clarifying the research evidence about controversial issues related to lymph node dissection in right hemicolectomy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: